Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepali Kumar

Showing results (41-50 of 231) with videos related to

Pageof 24
Sort By:
Transplantation|August 19, 2015
A Survey of Increased Infectious Risk Donor Utilization in Canadian Transplant ProgramsDeepali Kumar, Atul Humar, S Joseph Kim, et al.
Journal of Pain and Symptom Management|May 14, 2025
Challenges and Ethical Considerations of Palliative Care in Indian PrisonsSwapnil Kumar Barasker, Pankaj Singhai, Maya Nair, et al.
Transplantation|January 28, 2020
Innate and Adaptive Immune Correlates of Chronic and Self-limiting EBV DNAemia in Solid-organ Transplant RecipientsVictor H Ferreira, Judah Batist, Atul Humar, et al.
The Journal of Infectious Diseases|August 29, 2002
Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV diseaseAtul Humar, Deepali Kumar, Guy Boivin, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 20, 2021
Impact of immunosuppression on the immune response to SARS-CoV-2 infection: A mechanistic studyVictoria G Hall, Victor Ferreira, Deepali Kumar, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 6, 2017
Organ utilization from increased infectious risk donors: An observational studyArnaud G L'Huillier, Atul Humar, Clare Payne, et al.
Transplantation|January 1, 2013
Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profilingAdrian Egli, Deepali Kumar, Chris Broscheit, et al.
Transplantation|September 1, 2011
Clinical utility of molecular surveillance for cytomegalovirus after antiviral prophylaxis in high-risk solid organ transplant recipientsLuiz F Lisboa, Jutta K Preiksaitis, Atul Humar, et al.
The Journal of Infectious Diseases|May 2, 2003
Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipientsDeepali Kumar, Coleman Rotstein, Genevieve Miyata, et al.
Transplantation|December 20, 2011
Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremiaLuiz F Lisboa, Deepali Kumar, Leticia E Wilson, et al.
Pageof 24

Showing results (41-50 of 231) with videos related to

Sort By:
Pageof 24
Transplantation|August 19, 2015
A Survey of Increased Infectious Risk Donor Utilization in Canadian Transplant ProgramsDeepali Kumar, Atul Humar, S Joseph Kim, et al.
Journal of Pain and Symptom Management|May 14, 2025
Challenges and Ethical Considerations of Palliative Care in Indian PrisonsSwapnil Kumar Barasker, Pankaj Singhai, Maya Nair, et al.
Transplantation|January 28, 2020
Innate and Adaptive Immune Correlates of Chronic and Self-limiting EBV DNAemia in Solid-organ Transplant RecipientsVictor H Ferreira, Judah Batist, Atul Humar, et al.
The Journal of Infectious Diseases|August 29, 2002
Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV diseaseAtul Humar, Deepali Kumar, Guy Boivin, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 20, 2021
Impact of immunosuppression on the immune response to SARS-CoV-2 infection: A mechanistic studyVictoria G Hall, Victor Ferreira, Deepali Kumar, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 6, 2017
Organ utilization from increased infectious risk donors: An observational studyArnaud G L'Huillier, Atul Humar, Clare Payne, et al.
Transplantation|January 1, 2013
Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profilingAdrian Egli, Deepali Kumar, Chris Broscheit, et al.
Transplantation|September 1, 2011
Clinical utility of molecular surveillance for cytomegalovirus after antiviral prophylaxis in high-risk solid organ transplant recipientsLuiz F Lisboa, Jutta K Preiksaitis, Atul Humar, et al.
The Journal of Infectious Diseases|May 2, 2003
Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipientsDeepali Kumar, Coleman Rotstein, Genevieve Miyata, et al.
Transplantation|December 20, 2011
Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremiaLuiz F Lisboa, Deepali Kumar, Leticia E Wilson, et al.
Pageof 24